Medivir (Sweden)

Recent publications and citations

Top Concepts

Top subject area publications in last 5 years

Collaboration Analysis

Publications from 2021 to 2026

Latest Publications

Filter IconFilter

Showing 10 of 35 papers

  • Open Access
  • Research Article

OP0227 ASSESSMENT OF DIFFERENTIAL TREATMENT EFFECT BETWEEN PREDICTED ENDOTYPE SUBGROUPS OF KNEE OSTEOARTHRITIS IN THE MIV-711, UBX0101, AND ORAL SALMON CALCITONIN TRIALS

  • Jun 01, 2025
  • Annals of the Rheumatic Diseases
  • M Toft Hannani +11
  • Research Article
  • Citations1

First safety and efficacy data from phase Ib/IIa study of fostroxacitabine bralpamide (fostrox, MIV-818) in combination with lenvatinib in patients with hepatocellular carcinoma (HCC).

  • Jan 20, 2024
  • Journal of Clinical Oncology
  • Maria Reig +17
  • Research Article
  • Citations16

Symptomatic and structural benefit of cathepsin K inhibition by MIV-711 in a subgroup with unilateral pain: post-hoc analysis of a randomised phase 2a clinical trial.

  • May 01, 2022
  • Clinical and experimental rheumatology
  • A.r Bihlet +6
  • Open Access
  • Research Article
  • Citations66

Evaluation of ADMET Predictor in Early Discovery Drug Metabolism and Pharmacokinetics Project Work.

  • Nov 08, 2021
  • Drug metabolism and disposition: the biological fate of chemicals
  • Anna-Karin Sohlenius-Sternbeck +1
  • Abstract

The Thymidine Dideoxynucleoside Analogue, Alovudine, Inhibits the Mitochondrial DNA Polyermase, POLG, Impairs Oxidative Phosphorylation and Promotes Monocytic Differentiation in AML

  • Jun 25, 2021
  • Blood
  • Dana Yehudai-Ofir +11
  • Open Access
  • Discussion
  • Citations4

Novel L-nucleoside analog, 5-fluorotroxacitabine, displays potent efficacy against acute myeloid leukemia

  • Dec 19, 2019
  • Haematologica
  • Aniket Bankar +20
  • Book Chapter
  • Citations1

Preclinical Toxicology Evaluation

  • Aug 03, 2018
  • Sara Moses +2
  • Open Access
  • Research Article
  • Citations17

Six months’ treatment with MIV-711, a novel Cathepsin K inhibitor induces osteoarthritis structure modification: results from a randomized double-blind placebo-controlled phase IIA trial

  • Apr 01, 2018
  • Osteoarthritis and Cartilage
  • P.g Conaghan +16
  • Open Access
  • PDF
  • Research Article
  • Citations12

Quantitative Analysis of Hepatitis C NS5A Viral Protein Dynamics on the ER Surface

  • Jan 08, 2018
  • Viruses
  • Markus M Knodel +7
  • Research Article
  • Citations10

Co-refolding of a functional complex of Dengue NS3 protease and NS2B co-factor domain and backbone resonance assignment by solution NMR

  • Jul 24, 2017
  • Protein Expression and Purification
  • Esmeralda Woestenenk +4
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.